KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Revenue

KOREA PHARMA had revenue of 25.91B KRW in the quarter ending June 30, 2026, with 10.78% growth. This brings the company's total for the last twelve months to 93.94B, up 10.08% year-over-year. In the year 2025, KOREA PHARMA had annual revenue of 87.60B with 7.78% growth. That makes KOREA PHARMA the 25,325th largest company in the world by revenue and 1,486th in South Korea.

• Revenue (ttm): 93.94B
• Revenue Growth: +10.08%
• P/S Ratio: 0.93
• Revenue / Employee: 701.02M
• Employees: 134
• Market Cap: 87.58B

Revenue Chart

Chart

Chart

Revenue by Geography

• South Korea 77.98B 95.9%
• Overseas 3.30B 4.1%

Fiscal year ended Dec 31, 2024 See the full KOREA PHARMA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.60B	6.32B	7.78%
Dec 31, 2024	81.28B	-1.96B	-2.36%
Dec 31, 2023	83.24B	2.21B	2.73%
Dec 31, 2022	81.03B	1.45B	1.83%
Dec 31, 2021	79.58B	8.07B	11.28%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error